Assembly Biosciences Quick Ratio 2010-2023 | ASMB

Historical quick ratio values for Assembly Biosciences (ASMB) over the last 10 years.
Assembly Biosciences Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2023-09-30 $0.00B $0.01B 0.00
2023-06-30 $0.00B $0.01B 0.00
2023-03-31 $0.00B $0.01B 0.00
2022-12-31 $0.00B $0.02B 0.00
2022-09-30 $0.00B $0.02B 0.00
2022-06-30 $0.00B $0.02B 0.00
2022-03-31 $0.00B $0.01B 0.00
2021-12-31 $0.00B $0.02B 0.00
2021-09-30 $0.00B $0.02B 0.00
2021-06-30 $0.00B $0.01B 0.00
2021-03-31 $0.00B $0.01B 0.00
2020-12-31 $0.00B $0.02B 0.00
2020-09-30 $0.00B $0.02B 0.00
2020-06-30 $0.00B $0.02B 0.00
2020-03-31 $0.00B $0.02B 0.00
2019-12-31 $0.00B $0.02B 0.00
2019-09-30 $0.00B $0.02B 0.00
2019-06-30 $0.00B $0.02B 0.00
2019-03-31 $0.00B $0.03B 0.00
2018-12-31 $0.00B $0.02B 0.00
2018-09-30 $0.00B $0.02B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.01B 0.00
2017-06-30 $0.00B $0.01B 0.00
2017-03-31 $0.00B $0.01B 0.00
2016-12-31 $0.00B $0.01B 0.00
2016-09-30 $0.00B $0.01B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.00
2014-09-30 $0.00B $0.00B 0.00
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B 0.00
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B $0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.082B $0.007B
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.832B 5.36
Dr Reddy's Laboratories (RDY) India $11.868B 18.76
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.531B 0.00
Bausch Health Cos (BHC) Canada $3.154B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.993B 13.64
Supernus Pharmaceuticals (SUPN) United States $1.642B 0.00
Taysha Gene Therapies (TSHA) United States $0.497B 0.00
Generation Bio (GBIO) United States $0.246B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.032B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00